Funding for this research was provided by:
AstraZeneca France (No number assigned)
La ligue contre le cancer de Haute Normandie (no number)
Received: 14 January 2020
Accepted: 6 May 2020
First Online: 28 May 2020
Ethics approval and consent to participate
: This study was approved by the French National Drug Safety Agency (ANSM, 10 April 2015) and by an external ethics committee (Comité de protection des personnes Nord oust I, 26 March 2015). All patients provided informed consent before participation.
: Not applicable
: The authors declare that they have no competing interests.